<DOC>
	<DOCNO>NCT02241928</DOCNO>
	<brief_summary>The purpose study analyze effect autologous bone marrow mononuclear cell muscular dystrophy .</brief_summary>
	<brief_title>Stem Cell Therapy Muscular Dystrophy</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<criteria>age group 6 month muscular dystrophy diagnose basis clinical presentation presence respiratory distress presence acute infection Human Immunodeficient Virus/Hepatitis B Virus/Hepatitis C Virus malignancy acute medical condition respiratory infection , fever , hemoglobin le 8 , bleed tendency , bone marrow disorder , leave ventricular ejection fraction &lt; 30 % pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Muscular Dystrophy</keyword>
	<keyword>Autologous Mononuclear cell therapy</keyword>
	<keyword>Stem Cell</keyword>
</DOC>